Advertisement

Urticaria/Angioedema

The Mast Cell, Its Diverse Mediators, and Its Role in Cutaneous Inflammation
  • Nicholas A. Soter
  • K. Frank Austen
Part of the Comprehensive Immunology book series (COMIMUN, volume 7)

Abstract

An immediate type of immunological reaction, termed type I, anaphylactic, or mast-cell-dependent hypersensitivity (Gell and Coombs, 1963), results from the antigen-induced release of biologically active materials from mast cells sensitized with specific IgE antibody. In humans, the clinical symptom complex occurs rapidly after the exposure of a sensitive individual to the appropriate antigen. The sites of clinical expressions include the skin (urticaria/angioedema), the respiratory and gastrointestinal tracts, and the cardiovascular system; these sites may be involved singly or in any combination. Similar clinical syndromes may occur after direct nonimmunological mast cell degranulation or in association with abnormalities of the complement pathways or the arachidonic acid-prostaglandin systems. In the latter two circumstances, it is likely that the chemical mediators are wholly or in part distinct from mast cell sources.

Keywords

Mast Cell Chronic Urticaria Chronic Idiopathic Urticaria Serum Sickness Hereditary Angioedema 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agnello, V., Koffler, D., Eisenberg, J. W., Winchester, R. J., and Kunkel, H. G., 1971, Clq precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: Characterization of high and low molecular weight types, J. Exp. Med 134: 228s - 241s.PubMedGoogle Scholar
  2. Anwar, A. R. E., and Kay, A. B., 1977, The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors, Nature 269: 522–524.PubMedCrossRefGoogle Scholar
  3. Arroyave, C. M., and Tan, E. M., 1977, Mechanism of complement activation by radiographic contrast media, Clin. Exp. Immunol 29: 89–94.PubMedGoogle Scholar
  4. Arroyave, C. M., Bhat, K. N., and Crown, R., 1976, Activation of the alternative pathway of the complement system by radiographic contrast media, J. Immu-nol 117: 1866–1869.Google Scholar
  5. Arroyave, C. M., Stevenson, D. D., Vaughan, J. H., and Tan, E. M., 1977, Plasma complement changes during bronchospasm provoked in asthmatic patients, Clin. Allergy 7: 173–182.PubMedCrossRefGoogle Scholar
  6. Arroyave, C. M., Schatz, M., and Simon, R. A., 1979, Activation of the complement system by radiographic contrast media: Studies in vivo and in vitro, J. Allergy Clin. Immunol 63: 276–280.PubMedCrossRefGoogle Scholar
  7. Assem, E. S. K., and Mongar, J. L., 1970, Inhibition of allergic reactions in man and other species by cromoglycate, Int. Arch. Allergy Appl. Immunol 38: 68–77.PubMedCrossRefGoogle Scholar
  8. Atkins, P. C., Norman, M., Weiner, H., and Zweiman, B., 1977, Release of neutrophil chemotactic activity during immediate hypersensitivity reactions in humans, Ann. Intern. Med 86: 415–418.PubMedGoogle Scholar
  9. Atkins, P. C., Weiner, H., Norman, M., and Zweiman, B., 1978, Antigen induced neutrophil chemotactic activity in man, J. Allergy Clin. Immunol 62: 149–155.PubMedCrossRefGoogle Scholar
  10. Austen, K. F., Wasserman, S. I., and Goetz!, E. J., 1976, Mast cell-derived mediators: Structural and functional diversity and regulation of expression, in: Molecular and Biological Aspects of the Acute Allergic Reaction ( S. G. O. Johansson, K. S. Strandberg, and B. Uvnas, eds.), pp. 293–320, Plenum Press, New York.CrossRefGoogle Scholar
  11. Bach, M. K., Brashler, J. R., and Gorman, R. R., 1977, On the structure of slow reacting substance of anaphylaxis: Evidence of biosynthesis from arachidonic acid, Prostaglandins 14: 21–38.PubMedCrossRefGoogle Scholar
  12. Ballow, M., Ward, G. W., Jr., Gerschwin, M. E., and Day, N. K., 1975, Cl-bypass complement-activation pathway in patients with chronic urticaria and angiooedema, Lancet 2: 248–250.PubMedCrossRefGoogle Scholar
  13. Barnard, J. H., 1973, Studies of 400 hymenoptera sting deaths in the United States, J. Allergy Clin. Immunol 52: 259–264.PubMedCrossRefGoogle Scholar
  14. Bayaral, M., Orgel, H. A., and Hamburger, R. N., 1974, Genetics of IgE and allergy: Serum IgE levels in twins, J. Allergy Clin. Immunol 54: 288–304.CrossRefGoogle Scholar
  15. Becker, E. L., 1968, Nature and significance of antigen-antibody activated esterases, in: Biochemistry of the Acute Allergic Reactions (K. F. Austen and E. L. Becker, eds.), pp. 199–213, Blackwell, Oxford.Google Scholar
  16. Benveniste, J., 1974, Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils, Nature (London) 249: 581–582.CrossRefGoogle Scholar
  17. Bhat, K. N., Arroyave, C. M., Marney, S. R., Stevenson, D. D., and Tan, E. M., 1976, Plasma histamine changes during provoked bronchospasm in asthmatic patients, J. Allergy Clin. Immunol 58: 647–656.PubMedCrossRefGoogle Scholar
  18. Black, J. W., Duncan, W. A. M., Durant, C. J., Ganellin, C. R., and Parsons, E. M., 1972, Definition and antagonism of histamine H2-receptors, Nature (London) 236: 385–390.CrossRefGoogle Scholar
  19. Boswell, R. N., Austen, K. F., and Goetzl, E. J., 1978, Intermediate molecular weight eosinophil chemotactic factors in rat peritoneal mast cells: Immunologic release, granule association, and demonstration of structural heterogeneity, J. Immunol 120: 15–20.PubMedGoogle Scholar
  20. Brasch, R. C., Rochoff, S. D., Kuhn, C., and Chraplyvy, M., 1970, Contrast media as histamine releasers, Invest. Radio!. 5: 510–513.Google Scholar
  21. Brocklehurst, W. E., 1960, The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock, J. Physiol. (London) 151: 416–435.Google Scholar
  22. Brocklehurst, W. E., 1962, Slow reacting substance and related compounds, Progr. Allergy 6: 539–558.Google Scholar
  23. Bruce-Pearson, B. S., 1963, Hypersensitivity to aspirin, in: Salicylates (A. Dixon and K. B. Martin, eds.), pp. 170–173, Churchill, London.Google Scholar
  24. Caldwell, J. R., Ruddy, S., Schur, P. H., and Austen, K. F., 1972, Acquired CT inhibitor deficiency in lymphosarcoma, Clin. Immunol. Immunopathol 1: 39–52.CrossRefGoogle Scholar
  25. Caulfield, J. P., Lewis, R. A., Hein, A., and Austen, K. F., 1980, Secretion in dissociated human pulmonary mast cells: Involvement of intermediate filaments and evidence for solubilization of granule contents before discharge, J. Cell Biol 85: 299–312.PubMedCrossRefGoogle Scholar
  26. Center, D. M., Wasserman, S. I., Soter, N. A., and Austen, K. F., 1977, In vivo deactivation of human neutrophils to a subsequent in vitro stimulus, Clin. Res 25: 355A.Google Scholar
  27. Chafee, F. H., and Settipane, G. A., 1974, Aspirin intolerance. I. Frequency in an allergic population, J. Allergy Clin. Immunol 53: 193–199.CrossRefGoogle Scholar
  28. Champion, R. H., and Lachmann, P. J., 1969, Hereditary angio-oedema treated with e-aminocaproic acid, Br. J. Dermatol 81: 763–765.PubMedCrossRefGoogle Scholar
  29. Champion, R. H., Roberts, S. O. B., Carpenter, R. G., and Roger, J. H., 1969, Urticaria and angio-oedema: A review of 554 patients, Br. J. Dermatol 81: 588–597.PubMedCrossRefGoogle Scholar
  30. Christian, C. L., 1960a, Studies of aggregated}(-globulin. I. Sédimentation, electrophoretic and anticomplementary properties, J. Immunol 84: 112–116.PubMedGoogle Scholar
  31. Christian, C. L., 1960b, Studies of aggregatedY-globulin. II. Effect in vivo, J. Immunol 84: 117–121.PubMedGoogle Scholar
  32. Clark, R. A. F., Gallin, J. I., and Kaplan, A. P., 1975, The selective eosinophil chemotactic activity of histamine, J. Exp. Med 142: 1462 - -1476.PubMedCrossRefGoogle Scholar
  33. Comroe, J. E., and Dripps, R. D., 1946, Histamine-like action of curare and tubocurarine injected intracutaneously and intraarterially in man, Anesthesiology 7: 260–262.PubMedCrossRefGoogle Scholar
  34. Costanzi, J. J., and Coltman, J. R., 1967, Kappa chain cold precipitable immunoglobulin G (IgG) associated with cold urticaria. I. Clinical observations, Clin. Exp. Immunol 2: 167–178.PubMedGoogle Scholar
  35. Crissey, J. T., Ferguson, J. L., and Bettenhausen, J. M., 1965, Cutaneous thermography with liquid crystals, J. Invest. Dermatol 45: 329–333.PubMedGoogle Scholar
  36. Czarnetski, B M., König, W., and Lichtenstein, L. M., 1976a, Eosinophil chemotactic factor (ECF). I. Release from polymophonuclear leukocytes by the calcium ionophore A23187, J. Immunol 117:229–234.Google Scholar
  37. Czarnetski, B. M., König, W., and Lichtenstein, L. M., 1976b, Antigen-induced eosinophil chemotactic factor (ECF) release by human leukocytes, Inflammation 1: 201–215.Google Scholar
  38. Czarnetski, B. M., Kern, F., and Lichtenstein, L. M., 1976c, Defective release of eosinophil chemotactic factor from peripheral leukocytes in patients with chronic urticaria, J. Invest. Dermatol 67: 276–278.CrossRefGoogle Scholar
  39. Davis. P. J., Davis, F. B., and Charache, P., 1974, Longterm therapy of hereditary angioedema (HAE). Preventive management with fluoxymesterone and oxymethalone in severely affected males and females, Johns Hopkins Med. J 135: 391–398.PubMedGoogle Scholar
  40. Day, N. K., Winfield, J. B., Gee, T., Winchester, R., Teshima, H., and Kunkel, H. G., 1976, Evidence for immune complexes involving anti-lymphocyte antibodies associated with hypocomplementaemia in chronic lymphocytic leukemia (CLL), Clin. Exp. Im-munol 26: 189–195.Google Scholar
  41. Demopoulos, C. A., Pinckard, R. N., and Hanahan, D. J., 1979, Platelet activating factor: Evidence for 1-o-alkyl2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators), J. Biol. Chem 254: 9355–9358.PubMedGoogle Scholar
  42. Dixon, F. J., Vazquez, J. J., Weigle, W. O., and Cochrane, C. G., 1958, Pathogenesis of serum sickness, Arch. Pathol 65: 18–28.Google Scholar
  43. Dolovich, J., Hargreave, F. E., Chalmers, R., Shier, J., Gauldie, J., and Bienenstock, J., 1973, Late cutaneous allergic responses in isolated IgE-dependent reactions, J. Allergy Clin. Immunol 52: 38–46.PubMedCrossRefGoogle Scholar
  44. Donaldson, V. H., and Evans, R. R., 1963, A biochemical abnormality in hereditary angioneurotic edema: Absence of serum inhibitor of C’1-esterase, Am. J. Med 35: 37–44.PubMedCrossRefGoogle Scholar
  45. Donaldson, V. H., and Rosen, F. S., 1964, Action of complement in hereditary angioneurotic edema: Role of C’ 1-esterase, J. Clin. Invest 43: 2204–2213.PubMedCrossRefGoogle Scholar
  46. Donaldson, V. H., Merler, E., and Rosen, F. S., 1978, Polypeptide kinin from hereditary angioneurotic edema plasma, in: Clinical Aspects of the Complement System, ( W. Opferkuch, K. Rother, and D. R. Schultz, eds.), pp. 130–133, Thieme, Stuttgart.Google Scholar
  47. Douglas, W. W., 1975, Histamine and antihistamines; 5 hydroxytraptamine and antagonists, in: The Pharmacologic Basis of Therapy ( L. S. Goodman and A. Gilman, eds.), pp. 590–629, Macmillan, New York.Google Scholar
  48. Dousa, T. P., and Code, C. F., 1974, Effect of histamine and its methyl derivatives on cyclic AMP metabolism in gastric mucosa and its blockage by an H2 receptor antagonist, J. Clin. Invest 53: 334–337.PubMedCrossRefGoogle Scholar
  49. Drazen, J. M., and Austen, K. F., 1974, Effects of intravenous administration of slow-reacting substance of anaphylaxis, histamine, bradykinin, and prostaglandin F2 a on pulmonary mechanics in the guinea pig, J. Clin. Invest 53: 1679–1685.PubMedCrossRefGoogle Scholar
  50. Drazen, J. M., Lewis, R. A., Wasserman, S. I., Orange, R. P., and Austen, K. F., 1979, Differential effects of a partially purified preparation of slow-reacting substance of anaphylaxis on guinea pig tracheal spirals and parenchymal strips, J. Clin. Invest 63: 1–5.PubMedCrossRefGoogle Scholar
  51. Ellis, E., and Henney, C. S., 1969, Adverse reactions following administration of human gamma globulin, J. Allergy Clin. Immunol 43: 45–54.Google Scholar
  52. Engineer, D. M., Piper, P. J., and Sirois, P., 1976, Interaction between the release of SRS-A and of prostaglandins, Br. J. Pharmacol 57: 460P - 461 P.PubMedGoogle Scholar
  53. Farr, R. S., 1970, The need to re-evaluate acetyl salicylic acid (aspirin), J. Allergy 45: 321–328.PubMedCrossRefGoogle Scholar
  54. Frank, M. M., Sergent, J. S., Kane, M. A., and Ailing, D. W., 1972, Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: A double-blind study, N. Engl. J. Med 286: 808–812.PubMedCrossRefGoogle Scholar
  55. Frank, M. M., Gelfand, J. A., and Atkinson, J. P., 1976, Hereditary angioedema: The clinical syndrome and its management, Ann. Intern. Med 84: 580–593.PubMedGoogle Scholar
  56. Gelfand, J. A., Sherine, R. J., Ailing, D. W., and Frank, M. M., 1976, Treatment of hereditary angioedema with danazol: Reversal of clinical and biochemical abnormalities, N. Engl. J. Med 295: 1444–1448.PubMedCrossRefGoogle Scholar
  57. Gell, P. G. H., and Coombs, R. R. A., 1963, The classification of allergic reactions underlying disease, in: Clinical Aspects of Immunology ( P. G. H. Gell and R. R. A. Coombs, eds.), pp. 320–322, F. A. Davis, Philadelphia.Google Scholar
  58. Gleich, G. J., and Jacob, G. L., 1975, Immunoglobulin E antibodies to pollen allergens account for high percentages of total immunoglobulin E proteins, Science 190: 1106–1108.PubMedCrossRefGoogle Scholar
  59. Goetzl, E. J., 1978, Regulation of the polymorphonuclear leukocyte chemotactic response by immunological reactions, in: Leukocyte Chemotaxis (J. I. Gallin and P. G. Quie, eds.), pp. 161–177, Raven Press, New York.Google Scholar
  60. Goetzl, E. J., and Austen, K. F., 1975, Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: Identification as eosinophil chemotactic factor of anaphylaxis, Proc. Natl. Acad. Sci. USA 72: 4123–4127.PubMedCrossRefGoogle Scholar
  61. Goetzl, E. J., Ruddy, S., Stechschulte, D. J., and Austen, K. F., 1974, Immediate immunologic reactions: Noncytolytic mediator release and cytolytic cell destruction, in: Pharmacology and Pharmcokinetics ( T. Teorell, R. L. Dedrick, and P. G. Condliffe, eds), pp. 281–296, Plenum Press, New York.Google Scholar
  62. Granerus, G., Hallberg, L., Laurell, A.-B., and Wetterquist, H., 1967, Studies on the histamine metabolism and the complement system in hereditary angioneurotic edema, Acta Med. Scand 182: 11–22.PubMedCrossRefGoogle Scholar
  63. Greaves, M. W., Yamamoto, S., and Fairley, V. M., 1972, IgE-mediated hypersensitivity in human skin studied using a new in vitro technique, Immunology 23: 239–248.PubMedGoogle Scholar
  64. Greaves, W. M., Sneddon, I. B., Smith, A. K., and Stan-worth, D. R., 1974, Heat urticaria, Br. J. Dermatol 90: 289–292.PubMedCrossRefGoogle Scholar
  65. Greaves, M., Marks, R., and Robertson, I., 1977, Receptors for histamine in human skin blood vessels: A review, Br. J. Dermatol 97: 225–228.PubMedCrossRefGoogle Scholar
  66. Green, G. R., and Rosenblum, A., 1971, Report of the penicillin study group. American Academy of Allergy, J. Allergy Clin. Immunol 48: 331–343.PubMedCrossRefGoogle Scholar
  67. Harber, L. C., Holloway, R. M., Wheatley, V. R., and Baer, R. L., 1963, Immunologic and biophysical studies in solar urticaria, J. Invest. Dermatol 41: 439–443.PubMedCrossRefGoogle Scholar
  68. Hauptmann, G., Lang, J-M., North, M.-L., Oberling, F., Mayer, G., and Lachmann, P., 1976, Acquired CT-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities: A study of three cases, Blut 32: 195–206.PubMedCrossRefGoogle Scholar
  69. Hauptmann, G., Mayer, S., Lang, J.-M., Oberling, F., and Mayer, G., 1977, Treatment of acquired CT-inhibitor deficiency with danazol, Ann. Intern. Med 87: 577–578.PubMedGoogle Scholar
  70. Hellgren, L., and Hersle, K., 1964, Acute and chronic urticaria. A statistical investigation on clinical and laboratory data in 1204 patients and matched healthy controls, Acta Allergol. 19: 406–420.PubMedGoogle Scholar
  71. Henson, P. M., 1977, Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils: Characteristics of the aggregation and its dissociation from secretion, J. Clin. Invest 60: 481–490.PubMedCrossRefGoogle Scholar
  72. Hirsch, S. R., and Kalbfleisch, J. H., 1976, Circulating basophils in normal subjects and in subjects with hay fever, J. Allergy Clin. Immunol 58: 676–682.PubMedCrossRefGoogle Scholar
  73. Illig, L., and Heinicke, A., 1967, Zur pathogenese der cholinergischen urticaria. IV. Zur frage einer echten antigen-antikörperreaktion, Arch. Klin. Exp. Dermatol 229: 360–371.PubMedGoogle Scholar
  74. Ishizaka, K., Tomioka, H., and Ishizaka, T., 1970, Mech-anisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes, J. Immunol 105: 1459–1467.PubMedGoogle Scholar
  75. Jager, B. V., 1967, Intravenous administration of modified gamma globulin: Several studies on a patient with agammaglobulinemia, Arch. Intern. Med 199: 60–64.CrossRefGoogle Scholar
  76. Jakschik, B. A., Falkenhein, S., and Parker, C. W., 1977, Precursor role of arachidonic acid in release of slow reacting substance from rat basophil leukemia cells, Proc. Natl. Acad. Sci. USA 74: 4577–4581.PubMedCrossRefGoogle Scholar
  77. James, J., and Warin, R. P., 1971, An assessment of the role of Candida albicans and food yeasts in chronic urticaria, Br. J. Dermatol 84: 227–237.PubMedCrossRefGoogle Scholar
  78. James, L. P., Jr., and Austen, K. F., 1964, Fatal systemic anaphylaxis in man, N. Engl. J. Med 270: 597–603.PubMedCrossRefGoogle Scholar
  79. Kaliner, M., Orange, R. P., and Austen, K. F., 1972, Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. IV. Enhancement by cholinergic and a -adrenergic stimulation, J. Exp. Med 136: 556–557.PubMedCrossRefGoogle Scholar
  80. Kaliner, M. A., Wasserman, S. I., and Austen, K. F., 1973, Immunologic release of chemical mediators from human nasal polyps, N. Engl. J. Med 289: 277–281.PubMedCrossRefGoogle Scholar
  81. Kaplan, A. P., Gray, L., Shaff, R. E., Horakova, Z., and Beaven, M. A., 1975, In vivo studies of mediator release in cold urticaria and cholinergic urticaria, J. Allergy Clin. Immunol 55: 394–402.Google Scholar
  82. Kaplan, A. P., Hunt, K. J., Sobotka, A. K., Smith, P., Horakova, Z., Gralnick, H., and Lichtenstein, L. M., 1977, Human anaphylaxis: A study of mediator systems, Clin. Res 25: 361A.Google Scholar
  83. Kay, A. B., and Austen, K. F., 1971, The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung, J. Immunol 107: 899–902.PubMedGoogle Scholar
  84. Kay, A. B., Stechschulte, D. J., and Austen, K. F., 1971, An eosinophil leukocyte chemotactic factor of anaphylaxis, J. Exp. Med 133: 602–619.PubMedCrossRefGoogle Scholar
  85. Kern, F., and Lichtenstein, L. M., 1976, Defective histamine release in chronic urticaria, J. Clin. Invest 57: 1369–1377.PubMedCrossRefGoogle Scholar
  86. Kiernan, J. A., 1976, Evidence for the involvement of vasoactive constitutents of mast cells in axon reflex vasodilation in the skin of the rat, Arch. Dermatol. Res 255: 1–8.CrossRefGoogle Scholar
  87. Kirby, J. D., Matthews, C. N. A., James, J., Duncan, E. H. L., and Warin, R. P., 1971, The incidence and other aspects of factitious wealing (dermographism), Br. J. Dermatol 85: 331–335.PubMedCrossRefGoogle Scholar
  88. Kravis, T. C., and Henson, P. M., 1977, Accumulation of platelets at sites of antigen-antibody-mediated injury: A possible role for IgE antibody and mast cells, J. Immunol 118: 1569–1573.PubMedGoogle Scholar
  89. Lagunoff, D., 1972, Contributions of electron microscopy to the study of mast cells, J. Invest. Dermatol 58: 296–311.PubMedCrossRefGoogle Scholar
  90. Lagunoff, D., and Benditt, E. P., 1963, Proteolytic enzymes of mast cells, Ann. N.Y. Acad. Sci 103: 185–198.PubMedCrossRefGoogle Scholar
  91. Lagunoff, D., Pritzl, P., and Mueller, L., 1970, N-Acetyl-ß-glucosaminidase in rat mast cell granules, Exp. Cell. Res 61: 129–132.PubMedCrossRefGoogle Scholar
  92. Lasser, E. G., 1968, Basic mechanism of contrast media reactions, Radiology 91: 63–73.PubMedGoogle Scholar
  93. Laurell, A.-B., Martensson, U., and Sjöholm, A. G., 1977, Studies of CI subcomponents in chronic urticaria and angioedema, Int. Arch. Allergy Appl. Immunol 54: 434–442.PubMedCrossRefGoogle Scholar
  94. Leikola, J., Koistinen, J., Lehtinen, M., and Virolainen, M., 1973, IgA-induced anaphylactic transfusion reactions. A report of four cases, Blood 42: 111–119.PubMedGoogle Scholar
  95. Lepow, I. H., Willms-Kretschmer, K., Patrick, R. A., and Rosen, F. S., 1970, Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man, Am. J. Pathol 61: 13–24.PubMedGoogle Scholar
  96. Lever, W. F., and Schaumburg-Lever, G., 1975, Histopathology of the Skin, p. 133, Lippincott, Philadelphia.Google Scholar
  97. Lewis, R. A., Goetz!, E. J., Wasserman, S. I., Valone, F. H., Rubin, R. H., and Austen, K. F., 1975, The release of four mediators of immediate hypersensitivity from human leukemic eosinophils, J. Immunol 114: 87–92.PubMedGoogle Scholar
  98. Lewis, R. A., Roberts,.L. J., II, Holgate, S. T., Oates, J. A., and Austen, K. F., 1980a, Prostaglandin D2 production by rat and human mast cells activated by reversed anaphylaxis, Fed. Proc 39: 905.Google Scholar
  99. Lewis, R. A., Austen, K. F., Drazen, J. M., Clark, D. A., and Corey, E. J., 19806, Slow reacting substance of anaphylaxis: Identification of leukotrienes C-1 and D from human and rat sources, Proc. Natl. Acad. Sci. USA (in press).Google Scholar
  100. Lewis„ T., 1927, The Blood Vessels of the Human Skin and Their Responses, Shaw, London.Google Scholar
  101. Lichtenstein, L. M., and Gillespie, E., 1975, The effects of H1 and H2 antihistamines on “allergic” histamine release and its inhibition by histamine, J. Pharmacol. Exp. Ther 192: 441–450.PubMedGoogle Scholar
  102. Lichtenstein, L. M., and Oster, A. G., 1964, Studies on the mechanisms of hypersensitivity phenomena. IX. Histamine release from human leukocytes by ragweed pollen antigen, J. Exp. Med 120: 507–530.PubMedCrossRefGoogle Scholar
  103. Lichtenstein, L. M., Valentine, M. D., and Sobotka, A. K., 1974, A case for venom treatment in anaphylactic sensitivity to hymenoptera sting, N. Engl. J. Med 290: 1223–1227.PubMedCrossRefGoogle Scholar
  104. Lundh, B., Laurell, A. B., Wetterquist, H., White, T., and Granerus, G., 1968, A case of hereditary angioneurotic oedema, successfully treated with e-aminocaproic acid. Studies on C’ 1 esterase inhibitor, C’ 1 activation, plasminogen level, and histamine metabolism, Clin. Exp. Immunol 3: 733–745.PubMedGoogle Scholar
  105. Lynch, S. M., Austen, K. F., and Wasserman, S. I., 1978, Release of arylsulfatase A but not B from rat mast cells by non-cytolytic secretory stimuli, J. Immunol 121: 1394–1399.PubMedGoogle Scholar
  106. Majno, G., and Palade, G. E., 1961, Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability, J. Biophys. Biochem. Cytol 11: 571–605.PubMedCrossRefGoogle Scholar
  107. Marsh, D. G., 1976, Allergy: A model for studying the genetics of human immune response, in: Molecular and Biological Aspects of the Acute Allergic Reaction ( S. G. O. Johansson, K. S. Strandberg, and B. Uvnäs, eds.), pp. 23–57, Plenum Press, New York.CrossRefGoogle Scholar
  108. Marsh, D. G., Bias, W. B., and Ishizaka, K., 1974, Genetic control of basal serum immunoglobulin E level and its effect on specific reaginic specificity, Proc. Natl. Acad. Sci. USA 71: 3588–3592.Google Scholar
  109. Mathews, K. P., Hemphill, F. M., Lovell, R. G., Forsythe, W. E., and Sheldon, J. M., 1956, Controlled study on use of parenteral and oral antihistamines in preventing penicillin reactions, J. Allergy 27: 1–15.PubMedCrossRefGoogle Scholar
  110. Mathison, D. A., Arroyave, C. M., Bhat, K. N., Hurewitz, D. S., and Marnell, D. J., 1977, Hypocomplementemia in chronic idiopathic urticaria, Ann. Intern. Med 86: 534–538.PubMedGoogle Scholar
  111. McManus, L. M., Morley, C. A., Levine, S. P., and Pinckard, R. H., 1979, Platelet activating factor (PAF) induced release of platelet factor 4 (PF4) in vitro and during IgE anaphylaxis in the rabbit, J. Immunol 123: 2835–2841.PubMedGoogle Scholar
  112. McNeill, J. H., and Verma, S. C., 1974, Blockade by burimamide of the effects of histamine and histamine analogues on cardiac contractility, phosphorylase activation, and cyclic adenosine monophosphate, J. Pharmacol. Exp. Ther 188: 180–188.PubMedGoogle Scholar
  113. Metcalfe, D. D., Lewis, R. A., Silbert, J. E., Rosenberg, R. D., Wasserman, S. I., and Austen, K. F., 1979, Isolation, and characterization of heparin from human lung, J. Clin. Invest 64: 1537–1543.PubMedCrossRefGoogle Scholar
  114. Metcalfe, D. D., Wasserman, S. I., and Austen, K. F., 1980, Isolation and characterization of sulfated muco-polysaccharides from rat leukaemic (RBL-1) basophils, Biochem. J 185: 367–372.PubMedGoogle Scholar
  115. Michaëlsson, G., and Juhlin, L., 1973, Urticaria induced by preservatives and dye additives in food and drugs, Br. J. Dermatol 88: 525–532.PubMedCrossRefGoogle Scholar
  116. Mikhail, G. R., and Miller-Milinska, A., 1964, Mast cell population in human skin, J. Invest. Dermatol 43: 249–254.PubMedGoogle Scholar
  117. Moore-Robinson, M., and Warin, R. P., 1967, Effect of salicylates in urticaria, Br. Med. J 4: 262–265.PubMedCrossRefGoogle Scholar
  118. Murphy, R. C., Hammarström, S., and Samuelsson, B., 1979, Leukotriene C: A slow-reacting substance from murine mastocytoma cells, Proc. Natl. Acad. Sci. USA 76: 4275–4279.PubMedCrossRefGoogle Scholar
  119. Newball, H. H., Berninger, R. W., Talamo, R. C., and Lichtenstein, L. M., 1979a, Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization, J. Clin. Invest 64: 457–465.PubMedCrossRefGoogle Scholar
  120. Newball, H. H., Talamo, R. C., and Lichtenstein, L. M., 19756, Release of leukocyte kallikrein mediated by IgE, Nature (London) 254: 635–636.Google Scholar
  121. Newball, H. H., Berninger, R. W., Talamo, R. C., and Lichenstein, L. M., 1979a, Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization, J. Clin. Invest 64: 457–465.PubMedCrossRefGoogle Scholar
  122. Newball, H. H., Talamo, R. C., and Lichenstein, L. M., 19796, Anaphylactic release of a basophil kallikrein-like activity. II. A mediator of immediate hypersensitivity reactions, J. Clin. Invest 64: 466–475.Google Scholar
  123. Newcomb, R. W., and Nelson, H., 1973, Dermographia mediated by immunoglobulin E, Am. J. Med 54: 174–180.PubMedCrossRefGoogle Scholar
  124. Oishi, M., Takano, M., Miyachi, K., Ichikawa, Y., and Homma, M., 1976, A case of unusual SLE related syndrome characterized by erythema multiforme, angioneurotic edema, marked hypocomplementemia, and Clq precipitins of the low molecular weight type, Int. Arch. Allergy Appl. Immunol 50: 463–472.PubMedCrossRefGoogle Scholar
  125. Orange, R. P., and Austen, K. F., 1969, Slow reacting substance of anaphylaxis, Adv. Immunol 10: 105–144.PubMedCrossRefGoogle Scholar
  126. Orange, R. P., and Moore, E. G., 1976, Functional characterization of rat mast cell arylsulfatase activity, J. Immunol 117: 2191–2196.PubMedGoogle Scholar
  127. Orange, R. P., Austen, W. G., and Austen, K. F., 1971, Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3’,5’-adenosine monophosphate, J. Exp. Med 134: 136s - 148s.PubMedGoogle Scholar
  128. Orange, R. P., Murphy, R. C., Karnovsky, M. L., and Austen, K. F., 1973, The physicochemical characteristics and purification of slow reacting substance of anaphylaxis, J. Immunol 110: 760–770.PubMedGoogle Scholar
  129. Orange, R. P., Murphy, R. C., and Austen, K. F., 1974, Inactivation of slow reacting substance of anaphylaxis (SRS-A) by arylsulfatases, J. Immunol 113: 316–322.PubMedGoogle Scholar
  130. Orenstein, N. S., Galli, S. J., Hammond, M. E., Smith, G. N., Silbert, J. E., and Dvorak, H. F., 1978, Sulfated glycosaminoglycans of guinea pig basophilic leukocytes, J. Immunol 121: 586–592.PubMedGoogle Scholar
  131. Osier, W., 1888, Hereditary angio-neurotic oedema, Am. J. Med. Sci 95: 362–367.CrossRefGoogle Scholar
  132. Palmer, M. A., Piper, P. J., and Vane, J. R., 1973, Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea-pig lungs. Br. J. Pharmacol 49: 226–242.PubMedCrossRefGoogle Scholar
  133. Parker, C. W., 1975, Drug allergy, N. Engl. J. Med. 292:511–514, 732–736, 937–960.Google Scholar
  134. Patterson, R., Mellies, C. J., Blankenship, M. L., and Pruzansky, J. J., 1972, Vibratory angioedema: A hereditary type of physical hypersensitivity, J. Allergy Clin. Immunol 50: 174–182.PubMedCrossRefGoogle Scholar
  135. Pearce, C. A., Greaves, M. W., Plummer, V. M., and Yamamoto, S., 1974, Effect of disodium cromoglycate on antigen-evoked histamine release from human skin, Clin. Exp. Immunol 17: 437–440.PubMedGoogle Scholar
  136. Pence, H. L., Evans, R., Guernsey, L. H., and Gerhard, R. C., 1974, Prophylactic use of epsilon aminocaproic acid for oral surgery in a patient with hereditary angioneurotic edema, J. Allergy Clin. Immunol 53: 298–302.PubMedCrossRefGoogle Scholar
  137. Pinckard, R. H., Farr, R. S., and Hanahan, D. J., 1979, Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils, J. Immunol 123: 1847–1857.PubMedGoogle Scholar
  138. Plant, M., Lichtenstein, L. M., and Henney, C. S., 1975, Properties of a subpopulation of T cells bearing histamine receptors, J. Clin. Invest 55: 856–874.CrossRefGoogle Scholar
  139. Roberts, L. J., II, Lewis, R. A., Oates, J. A., and Austen, K. F., 1979, Prostaglandin, thromboxane, and 12 hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells, Biochem. Biophys. Acta 575: 185–192.PubMedCrossRefGoogle Scholar
  140. Roberts, L. J., II, Sweetman, B. J., Lewis, R. A., Folarin, V. F., Austen, K. F., and Oates, J. A., 1980, Markedly increased synthesis of prostaglandin D2 in mastocytosis, Clin. Res 28: 552A.Google Scholar
  141. Ros, A. M., Juhlin, L., and Michaëlsson, G., 1976, A follow-up study of patients with recurrent urticaria and hypersensitivity to aspirin, benzoates, and azo dyes, Br. J. Dermatol 05: 19–24.CrossRefGoogle Scholar
  142. Rose, B., 1941, Studies on blood histamine in cases of allergy. I. Blood histamine during wheal formation, J. Allergy 12: 327–334.CrossRefGoogle Scholar
  143. Rosen, F. S., Charache, P., Pensky, J., and Donaldson, V., 1965, Hereditary angioneurotic edema: Two genetic variants, Science 148: 957–958.PubMedCrossRefGoogle Scholar
  144. Rosenfeld, S. I., Staples, P. J., and Leddy, J. P, 1975, Angioedema and hypocomplementemia: Unusual feature of lymphoma, J. Allergy Clin. Immunol 55: 104Google Scholar
  145. Rosse, W. F., Logue, G. L., Silberman, H. R., and Frank, M. M., 1976, The effect of synthetic androgens in hereditary angioneurotic edema: Alteration of Cl inhibitor and C4 levels, Tr. Assoc. Am. Physicians 89: 122–132.Google Scholar
  146. Ruddy, S., and Austen, K. F., 1967, A stoichiometric assay for the fourth component of complement in whole human serum using EAC’ la HP and functionally pure human second component, J. Immunol 99: 1162–1172.PubMedGoogle Scholar
  147. Ruddy, S., Carpenter, C. B., Müller-Eberhard, H. J., and Austen, K. F., 1968, Complement component levels in hereditary angioneurotic edema and isolated C’2 deficiency in man, in: Mechanisms of Inflammation Induced by Immune Reactions. Fifth Immúnopathology International Symposium ( P. A. Miescher and P. Grabar, eds.), pp. 231–251, Schwabe, Basel.Google Scholar
  148. Ruddy, S., Carpenter, C. B., Chin, K. W., Knostman, J. N., Soter, N. A., Götze, O., Müller-Eberhard, H. J., and Austen, K. F., 1975, Human complement metabolism: An analysis of 144 studies, Medicine 54: 165–178.Google Scholar
  149. Rudzki, E., Borkowski, W., and Czubalski, K., 1970, The suggestive effect of placebo on the intensity of chronic urticaria, Ann. Allergy 25: 70–73.Google Scholar
  150. Ryan, T. J., Shim-Young, N., and Turk, J. L., 1968, Delayed pressure urticaria, Br. J. Dermatol 80: 485–490.PubMedCrossRefGoogle Scholar
  151. Sams, W. M., Jr., Epstein, J. H., and Winkelmann, R. K., 1969, Solar urticaria: Investigation of pathogenetic mechanisms, Arch. Dermatol 99: 390–397.PubMedCrossRefGoogle Scholar
  152. Samter, M., and Beers, R. J., Jr., 1967, Concerning the nature of intolerance to aspirin, J. Allergy 40: 281–293.PubMedCrossRefGoogle Scholar
  153. Schatz, M., Patterson, R., O’Rourke, J., Nickelson, J., and Northrup, C., 1975, The administration of radiographic contrast media to patients with a history of previous reaction, J. Allergy Clin. Immunol 55: 358–366.PubMedCrossRefGoogle Scholar
  154. Schayer, R. W., 1965, Histamine and circulatory homeostasis, Fed. Proc 24: 1295–1297.PubMedGoogle Scholar
  155. Schmidt, A. P., Taswell, H. F., and Gleich, G. J., 1969, Anaphylactic transfusion reactions associated with anti-IgA antibody, N. Engl. J. Med 280: 188–193.PubMedCrossRefGoogle Scholar
  156. Schoenfeld, M. R., 1960, Acute allergic reactions to morphine, codeine, meperidine hydrochoride, and opium alkaloids, N.Y. J. Med 60: 2591–2593.Google Scholar
  157. Schreiber, A. D., Zweiman, B., Atkins, P., Goldwein, F., Pietra, G., Atkinson, B., and Abdou, N. I., 1976, Acquired angioedema with lymphoproliferative disorder: Association of Cl inhibitor deficiency with cellular abnormality, Blood 48: 567–580.PubMedGoogle Scholar
  158. Schwartz, L. B., and Austen, K. F., 1980, Enzymes of the mast cell granule, J. Invest. Dermatol 74: 349–353.PubMedCrossRefGoogle Scholar
  159. Schwartz, L. B., Austen, K. F., and Wasserman, S. I., 1979, Immunologic release of ß-hexosaminidase and ßglucuronidase from purified rat serosal mast cells, J. Immunol 123: 1445–1450.PubMedGoogle Scholar
  160. Schwartz, L. B., Lewis, R. A., and Austen, K. F., 1980, Immunologic release of hexosaminidase (Hex), glucuronidase (Gu), arylsulfatase (As), and tryptase activity from dispersed human pulmonary mast cells, Clin. Res 28: 559A.Google Scholar
  161. Settipane, G. A., and Pudupakkam, R. K., 1975, Aspirin intolerance. III. Subtypes, familial occurrence, and cross-reactivity with tartrazine, J. Allergy Clin. Immunol 56: 215–221.PubMedCrossRefGoogle Scholar
  162. Sheard, P., and Blair, A. M. J. N., 1970, Disodium cromoglycate: Activity in three in vitro models of the immediate hypersensitivity reaction in lung, Int. Arch. Allergy Appl. Immunol 38: 217–224.PubMedCrossRefGoogle Scholar
  163. Sheffer, A. L., and Austen, K. F., 1980, Exercise-induced anaphylaxis, J. Allergy Clin. Immunol (in press).Google Scholar
  164. Sheffer, A. L., Craig, J. M., Willms-Kretschmer, K., Austen, K. F., and Rosen, F. S., 1971, Histopathological and ultrastructural observations on tissues from patients with hereditary angioneurotic edema, J. Allergy 47: 292–297.PubMedGoogle Scholar
  165. Sheffer, A. L., Austen, K. F., and Rosen, F. S., 1972, Tranexamic acid therapy in hereditary angioneurotic edema, N. Engl. J. Med 287: 452–454.PubMedCrossRefGoogle Scholar
  166. Sheffer, A. L., Fearon, D. T., Austen, K. F., and Rosen, F. S., 1977a, Tranexamic acid: Preoperative prophylactic therapy for patients with hereditary angioneurotic edema (HAE), J. Allergy Clin. Immunol 60: 38–40.PubMedCrossRefGoogle Scholar
  167. Sheffer, A. L., Fearon, D. T., and Austen, K. F., 1977b, Methyltestosterone therapy in hereditary angioedema, Ann. Intern. Med 86: 306–308.PubMedGoogle Scholar
  168. Sheffer, A. L., Fearon, D. T., and Austen, K. F., 1979, Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema, J. Allergy Clin. Immunol 64: 275–280.PubMedCrossRefGoogle Scholar
  169. Sherman, W. B., and Seebohm, P. M., 1950, Passive transfer of cold urticaria, J. Allergy 21: 414–424.PubMedCrossRefGoogle Scholar
  170. Sobotka, A. K., Adkinson, N. F., Jr., Valentine, M. D., and Lichtenstein, L. M., 1978, Allergy to insect stings. IV. Diagnosis by radioallergosorbent test (RAST) J. Immunol. 121: 2477–2484.PubMedGoogle Scholar
  171. Solley, G. O., Gleich, G. J., Jordon, R. E., and Schroeter, A. L., 1976, The late phase of the immediate wheal and flare skin reactions. Its dependence upon IgE antibodies, J. Clin. Invest 58: 408–420.PubMedCrossRefGoogle Scholar
  172. Soter, N. A., 1977, Chronic urticaria as a manifestation of necrotizing venulitis, N. Engl. J. Med 296: 1440–1442.PubMedCrossRefGoogle Scholar
  173. Soter, N. A., Mihm, M. C., Jr., Gigli, I., Dvorak, H. F., and Austen, K. F., 1976a, Two distinct cellular patterns in cutaneous necrotizing angiitis, J. Invest. Dermatol 66: 344–350.PubMedCrossRefGoogle Scholar
  174. Soter, N. A., Wasserman, S. I., and Austen, K. F., 1976b, Cold urticaria: Release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge, N. Engl. J. Med 294: 687–690.PubMedCrossRefGoogle Scholar
  175. Soter, N. A., Joshi, N. P., Twarog, F. J., Zeiger, R. S., Rothman, P., and Cotten, H. R., 1977, Delayed cold-induced urticaria: A dominantly inherited disorder, J. Allergy Clin. Immunol 59: 294–297.PubMedCrossRefGoogle Scholar
  176. Soter, N. A., Mihm, M. C., Jr., Dvorak, H. F., and Austen, K. F., 1978, Cutaneous necrotizing venulitis: A sequential analysis of the morphologic alterations occurring after mast cell degranulation in a patient with a unique syndrome, Clin. Exp. Immunol 32: 46–58.PubMedGoogle Scholar
  177. Soter, N. A., Wasserman, S. I., Pathak, M. A., Parrish, J. A., and Austen, K. F., 1979, Solar urticaria: Release of mast cell mediators into the circulation after experimental challenge, J. Invest. Dermatol 72: 282.Google Scholar
  178. Soter, N. A., Wasserman, S. I., Austen, K. F., and McFadden, E. R., Jr., 1980, Mast cell mediator release and alteration in lung function in individuals with cholinergic urticaria, N. Engl. J. Med 302: 604–608.PubMedCrossRefGoogle Scholar
  179. Spark, R. P., 1971, Fatal anaphylaxis due to oral penicillin, Clin. Pathol 56: 407–411.Google Scholar
  180. Spaulding, W. B., 1960, Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema), Ann. Intern. Med 53: 739–745.Google Scholar
  181. Stevenson, D. D., Arroyave, C. M., Bhat, K. N., and Tan, E. M., 1976, Oral aspirin challenges in asthmatic patients: A study of plasma histamine, Clin. Allergy 6: 493–505.PubMedCrossRefGoogle Scholar
  182. Szczeklik, A., Gryglewski, R. J., Czerniawska-Mysik, G., and Zmuda, A., 1976, Aspirin-induced asthma: Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymic preparations, J. Allergy Clin. Immunol 58: 10–18.PubMedCrossRefGoogle Scholar
  183. Takatsu, K., Ishizaka, K., and King, T. P., 1975, Immunologic properties of modified antigen E. III. Effect of repeated injections of modified antigen on immunocompetent cells specific for native antigen, J. Immunol 115: 1469–1476.Google Scholar
  184. Tauber, A. I., Kaliner, M., Stechschulte, D. J., and Austen, K. F., 1973, Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. V. Effects of prostaglandins on release of histamine, J. Immunol 111: 27–32.PubMedGoogle Scholar
  185. Tindall, J. P., Beeker, S. K., and Rosse, W. F., 1969, Familial cold urticaria: A generalized reaction involving leukocytosis, Arch. Intern. Med 124: 129–134.PubMedCrossRefGoogle Scholar
  186. Trotter, C. M., and Orr, T. S. C., 1974, A fine structure study of some cellular components in allergic reactions. H. Mast cells in normal and atopic human skin, Clin. Allergy 4: 421–433.CrossRefGoogle Scholar
  187. Turnbull, L. W., Evans, D. P., and Kay, A. B., 1977, Human eosinophils, acidic tetrapeptides (ECF-A), and histamine: Interactions in vitro and in vivo, Immunology 32: 57–63.PubMedGoogle Scholar
  188. Vallota, E. H., and Miiller-Eberhard, H. J., 1973, Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator, J. Exp. Med 137: 1109–1122.PubMedCrossRefGoogle Scholar
  189. Van Arsdel, P. P., 1968, The risk of penicillin reactions, Ann. Intern Med 69: 10711–073.Google Scholar
  190. Vyas, G. N., and Fudenberg, H. H., 1969, Iso-immune anti-IgA causing anaphylactoid transfusion reactions, N. Engl. J. Med 280: 1073–1074.PubMedCrossRefGoogle Scholar
  191. Vyas, G. N., Holmdahl, L., Perkins, H. A., and Fudenberg, H. H., 1969, Serologic specificity of human antiIgA and its significance in transfusion, Blood 34: 573–581.PubMedGoogle Scholar
  192. Wasserman, S. I., and Austen, K. F., 1976, Arylsulfatase B of human lung: Isolation, characterization, and interaction with slow reacting substance of anaphylaxis, J. Clin. Invest 57: 738–744.PubMedCrossRefGoogle Scholar
  193. Wasserman, S. I., Goetzl, E. J., and Austen, K. F., 1975, Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase, J. Immunol 114: 645–649.PubMedGoogle Scholar
  194. Wasserman, S. I., Soter, N. A., Center, D. M., and Austen, K. F., 1977, Cold urticaria: Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge, J. Clin. Invest 60: 189–196.PubMedCrossRefGoogle Scholar
  195. Wasserman, S. I., Sheffer, A. L., Soter, N. A., Austen, K. F., and McFadden, E. R., 1978, Assessment of mast cell mediators and pulmonary function in aspirin (ASA)-induced bronchospasm, J. Allergy Clin. Immunol 61: 139.CrossRefGoogle Scholar
  196. Wasserman, S. I., Soter, N. A., Poser, J., and Austen, K. F., 1980, Eosinophil chemotactic factors in human disease: Evidence of heterogeneity, Clin. Res 28: 254A.Google Scholar
  197. Webster, M. E., Horakova, Z., Beaven, M. A., Takahashi, H., and Newball, H. H., 1974, Release of arginine esterase and histamine from human lung previously sensitized with ragweed antibody, Fed. Proc 33: 761.Google Scholar
  198. Weigle, W. O., and Dixon, F. J., 1958, Relationship of circulating antigen-antibody complexes, antigen elimination and complement in serum sickness, Proc. Soc. Exp. Biol. Med 99: 226–231.PubMedGoogle Scholar
  199. Weiss, S., Robb, C. P., and Ellis, L. B., 1932, The systemic effects of histamine in man: With special refer-ence to the responses of the cardiovascular system, Arch. Intern. Med 49: 360–396.CrossRefGoogle Scholar
  200. Wells, J. V., Buckley, R. H., Schonfield, M. S., and Fudenberg, H. H., 1977, Anaphylactic reactions to plasma infusions in patients with hypogammaglobulinemia and anti-IgA antibodies, Clin. Immunol. Immunopathol 8: 265–271.PubMedCrossRefGoogle Scholar
  201. Whitten, D. M., 1975, Reaction to urographic contrast media, J. Am. Med. Assoc 231: 974–977.CrossRefGoogle Scholar
  202. Wuepper, K. D., Bokisch, V. A., Müller-Eberhard, J. H., and Stoughton, R. B., 1972, Cutaneous responses to human C3 anaphylatoxin in man, Clin. Exp. Immunol 11: 13–20.PubMedGoogle Scholar
  203. Yurchak, A. M., Wicher, K., and Arbesman, C. E., 1970, Immunologic studies on aspirin, J. Allergy 46: 245–253.PubMedCrossRefGoogle Scholar
  204. Yurt, R. W., and Austen, K. F., 1977, Preparative purification of the rat mast cell chymase: Characterization and interaction with granule components, J. Exp. Med 146: 1405–1419.PubMedCrossRefGoogle Scholar
  205. Yurt, R. W., Leid, R. W., Austen, K. F., and Silbert, J. E., 1977, Native heparin from rat peritoneal mast cells, J. Biol. Chem 252: 518–521.PubMedGoogle Scholar
  206. Zweiman, B., and Hildreth, E. A., 1974, An approach to contrast studies in reactive humans, J. Allergy Clin. Immunol 53: 97.Google Scholar

Copyright information

© Plenum Publishing Corporation 1981

Authors and Affiliations

  • Nicholas A. Soter
    • 1
    • 2
    • 3
  • K. Frank Austen
    • 1
    • 2
    • 3
  1. 1.Departments of Dermatology and MedicineHarvard Medical SchoolBostonUSA
  2. 2.the Divisions of DermatologyBostonUSA
  3. 3.Departments of Medicine, Robert B. Brigham and PeterBent Brigham Divisions of the Affiliated Hospitals CenterBostonUSA

Personalised recommendations